2 completed, 1 recruiting, 1 terminated. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Recruiting 1, Terminated 1 |
Follow HBV: new trials by email Literature Review of HBV trials Research Report on HBV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1b, Open-label Study of Tune-401 to Assess Safety, PK and PD in Adults With Chronic Hepatitis B Tune-401 - Chronic Hep B, Chronic Hepatitis b | Phase 1 | Recruiting | Tune Therapeutics, Inc. | 36 | 2024-11-29 | 2026-01-06 |
| A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Entecavir Extended Release (XR) in Healthy Subjects Entecavir - HBV | Phase 1 | Completed | Aucta Pharmaceuticals, Inc | 40 | 2017-10-20 | 2018-06-27 |
| A Study of ALN-HBV in Healthy Adult Volunteers and Non-cirrhotic Patients With Chronic Hepatitis B Virus (HBV) Infection ALN-HBV, Sterile Normal Saline (0.9% NaCl) - Hepatitis B, Chronic Hepatitis B | Phase 1 | Terminated | Alnylam Pharmaceuticals | 24 | 2016-06-24 | 2018-09-24 |
| A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B Single Ascending Dose (SAD) Cohorts GS-9620, Multiple Ascending Dose (MAD) Cohorts - Hepatitis B, HBV | Phase 1 | Completed | Gilead Sciences | 49 | 2012-04-01 | 2013-11-14 |
Hepatitis B (2) · Hepatitis B, Chronic (2) · Hepatitis (1) · Hepatitis, Chronic (1)
Blood-Borne Infections (3) · Communicable Diseases (3) · DNA Virus Infections (3) · Digestive System Diseases (3) · Hepadnaviridae Infections (3) · Hepatitis, Viral, Human (3) · Infections (3) · Liver Diseases (3) · Virus Diseases (3) · Chronic Disease (2) · Disease Attributes (2) · Hepatitis (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Hepatitis B (1)
Cohort Studies (1) · Sagittal Abdominal Diameter (1) · entecavir (1) · mycophenolic adenine dinucleotide (1)
Alnylam Pharmaceuticals (1) · Aucta Pharmaceuticals, Inc (1) · Gilead Sciences (1) · Tune Therapeutics, Inc. (1)
Australia (3) · New Zealand (3) · Hong Kong (2) · South Korea (2) · Canada (1) · Moldova (1) · Singapore (1) · United Kingdom (1) · United States (1)
Benedetta Massetto, M.D. (1) · Stephen Huang, MD (1)